期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF ORTHOPAEDIC RESEARCH LetPub Score 6.6
50 ratings
Rate
Reputation 7.5 Influence 5.4 Speed 9.0 | ||||||||||||||||
期刊簡稱 | J ORTHOP RES | ||||||||||||||||
ISSN | 0736-0266 | ||||||||||||||||
E-ISSN | 1554-527X | ||||||||||||||||
h-index | 140 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.80%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1554-527X | ||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/jores | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1983 | ||||||||||||||||
每年文章數 | 215每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 22.60% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0736-0266%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[JOURNAL OF ORTHOPAEDIC RESEARCH] 的評論 | 撰寫評論 |
作者: 一匹小红牛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-05 16:28:52 評論於 Receiving manuscript fees(0) 讚! | 一匹小红牛 |
作者: 方岳霖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-08 20:21:08 評論於 May I ask if this magazine requires a review fee?(0) 讚! | 方岳霖 |
作者: 骨科青年 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-04-11 19:30:43 評論於 As a relatively good journal in orthopedics, the following timeline is provided for reference: submission on November 29th, major revision on January 16th, revision return on February 24th, and acceptance on March 31st. Before 2021, the journal was classified as a 2nd tier (zone) in orthopedics. However, starting from 2022, it has been reclassified as a 3rd tier (zone) by the Chinese Academy of Sciences, with an impact factor of 3.494. Although it is now a 3rd tier journal, it is still recommended for colleagues who conduct experiments with a funding investment of 50,000 or more to submit their excellent articles here.(0) 讚! | 骨科青年 |
作者: 五河向雁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-11 16:49:40 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Focus research direction: Biomechanics; Orthopedic experience sharing: Submitted on November 29, revised on January 16, revised again on February 24, and accepted on March 31. Questions were raised by two reviewers, mainly involving modifications to certain discussions. When writing articles, it is important to be specific, logical, and to resolve any potential experimental method issues. The review fee is $50, and the article layout fee can be open access (approximately $3600) or subscription-based (free(0) 讚! | 五河向雁 |
作者: meng 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-03-23 07:37:19 評論於 Posted on July 31, 2021, major renovation on December 4th; returned on January 18, 2022, minor repair on February 21; returned on March 7, notified acceptance on the 22nd.(0) 讚! | meng |
作者: meng 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-03-23 07:34:29 評論於 The journal is a well-established one with a longer review cycle.(0) 讚! | meng |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:57:07 評論於 For example, the experimental techniques of PCR, Western blot, and the usage methods of some instruments(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:16:30 評論於 If the method is described for the first time, it should be detailed to demonstrate the rigor and thorough consideration of the research work; however, if the method has already been described in a previously published paper, a brief description is sufficient with a reference to the original publication(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:14:50 評論於 When should the methods section be detailed and when can it be abbreviated?(0) 讚! | 北国博达 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 12:19:09 評論於 What is the standard operating procedure for laboratory use?(0) 讚! | 八坂篷蔚 |
作者: Silly74559 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-08-17 18:04:21 評論於 Old-established journal, with a good reputation, but a low impact factor. The review speed is average, I happened to submit it around Christmas, so it was relatively slow.(0) 讚! | Silly74559 |
作者: 犬走安兴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-28 15:41:38 評論於 Do you accept cases?(0) 讚! | 犬走安兴 |
作者: 东风向笛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-15 22:58:30 評論於 Submitted on 6.15, it has been exactly three months today. There have been several reviewers changed during the process, feeling quite nervous. I really hope it won't be rejected again(0) 讚! | 东风向笛 |
作者: 范凡 領域: 生物 審稿時間: 4.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-15 00:52:03 評論於 I have been waiting for three months for the reviewers’ comments. (0) 讚! | 范凡 |
作者: 拂柳金枝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-13 18:58:49 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: $50, then under review the next day, happily waiting, rejected without review after 18 days, feeling confused, submit cautiously, submit carefully(0) 讚! | 拂柳金枝 |
作者: 灵犀逸龙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-28 19:22:50 評論於 After the first review lasting for 3 months with three reviewers raising different questions, the paper was accepted for publication without further revisions after addressing them(0) 讚! | 灵犀逸龙 |
作者: hover 領域: 医药科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-05-28 15:02:26 評論於 First trial for 3 months, 3 reviewers asked different questions, after serious answer, after 2 months of the second trial directly received(0) 讚! | hover |
作者: 四风玉泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-28 09:18:06 評論於 After the first review which took 3 months, three reviewers raised different questions. After carefully addressing these questions, the paper was accepted without further revisions after the second review which took 2 months(0) 讚! | 四风玉泽 |
作者: dark robe wizard 領域: 生命科学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2018-02-17 14:50:35 評論於 has been rejected for 2 weeks, and the editor said that my content is not very innovative, lacks influence, and does not go deep.(0) 讚! | dark robe wizard |
作者: 法慧才良 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-02-17 10:35:01 評論於 Rejected after 2 weeks of submission, the editor said my content lacks originality, impact, and depth(0) 讚! | 法慧才良 |
作者: 是康时吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-02-09 23:47:20 評論於 What is the situation behind this? jvlangtaotian 2016-10-21 published:SCI(2015):2.807 SCI(2014):2.986 The next day it is already under review. Does this mean it is being sent for external review?(0) 讚! | 是康时吖 |
作者: 是康时吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-02-09 10:35:10 評論於 How about now? It has been 20 days since the major revision was sent back. Still no news(0) 讚! | 是康时吖 |
作者: 会心白旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-13 10:25:19 評論於 How long does it usually take to hear back after a major revision?(0) 讚! | 会心白旋 |
作者: 经义殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-03 13:26:30 評論於 This magazine has high requirements(0) 讚! | 经义殿下 |
作者: 坠星羽腾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-26 20:14:12 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: It's so unfortunate, rejected in just two days, without external review, and still paid the review fee(0) 讚! | 坠星羽腾 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us